SCHEMBL26415469

SCHEMBL26415469

c1ccc(-c2nc(-c3ccc(-c4cc(N(c5ccccc5)c5ccccc5)cc5oc6ccccc6c45)cc3)nc(-c3ccc4ccccc4c3)n2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.38
ALDH1A1 P00352 5/20 0.38
HSD17B10 Q99714 2/20 0.38
KMT2A Q03164 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
CYP1A2 P05177 2/20 0.38
MEN1 O00255 1/20 0.38
TP53 P04637 1/20 0.38
POLB P06746 2/20 0.34
MAPT P10636 7/20 0.33
CCR4 P51679 1/20 0.32
NR1H4 Q96RI1 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
TSHR P16473 2/20 0.32
HPGD P15428 2/20 0.32
ALOX15 P16050 1/20 0.32
CASP1 P29466 1/20 0.32
CASP7 P55210 1/20 0.32
PDE5A O76074 2/20 0.32
RAB9A P51151 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25975709 0.95 KDM4E (0.36) KDM4EALDH1A1HSD17B10KMT2ASMN1; SMN2
SCHEMBL24066124 0.94 KDM4E (0.36) KDM4EALDH1A1HSD17B10KMT2ASMN1; SMN2
SCHEMBL24255422 0.94 KDM4E (0.36) KDM4EALDH1A1HSD17B10KMT2ASMN1; SMN2
SCHEMBL26415453 0.92 ALDH1A1 (0.36) KDM4EALDH1A1HSD17B10KMT2ASMN1; SMN2
SCHEMBL25666438 0.90 MAPT (0.33) KDM4EALDH1A1HSD17B10KMT2ASMN1; SMN2
SCHEMBL25975707 0.89 ALDH1A1 (0.33) KDM4EALDH1A1HSD17B10KMT2ASMN1; SMN2
SCHEMBL24899569 0.89 KDM4E (0.34) KDM4EALDH1A1HSD17B10KMT2ASMN1; SMN2
SCHEMBL26415521 0.89 KDM4E (0.34) KDM4EALDH1A1HSD17B10KMT2ASMN1; SMN2
SCHEMBL22112415 0.88 ALDH1A1 (0.36) KDM4EALDH1A1HSD17B10KMT2ASMN1; SMN2
SCHEMBL25975774 0.88 CYP1A1 (0.37) KDM4EALDH1A1HSD17B10KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230128360-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME, COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT EMITTING DEVICE LT MATERIALS CO., LTD. (KR) 2023-04-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230128360-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME, COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT EMITTING DEVICE CRY1, ORC3, ODC1 KDM4E 3080/4885ALDH1A1 27/4885HSD17B10 1300/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.